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Recent studies suggest that intestinal microbiota influences gut-brain communication. In
this study, we aimed to clarify the influence of intestinal microbiota on cerebral metab-
olism. We analyzed the cerebral metabolome of germ-free (GF) mice and Ex-GF mice,
which were inoculated with suspension of feces obtained from specific pathogen-free
mice, using capillary electrophoresis with time-of-flight mass spectrometry (CE-TOFMS).
CE-TOFMS identified 196 metabolites from the cerebral metabolome in both GF and Ex-GF
mice.The concentrations of 38 metabolites differed significantly (p<0.05) between GF and
Ex-GF mice. Approximately 10 of these metabolites are known to be involved in brain func-
tion, whilst the functions of the remainder are unclear. Furthermore, we observed a novel
association between cerebral glycolytic metabolism and intestinal microbiota. Our work
shows that cerebral metabolites are influenced by normal intestinal microbiota through
the microbiota-gut-brain axis, and indicates that normal intestinal microbiota closely con-
nected with brain health and disease, development, attenuation, learning, memory, and
behavior.
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INTRODUCTION
Intestinal microbiota play a fundamentally important role in
health and diseases (Backhed et al., 2005). Recently, the rela-
tionship between intestinal microbiota and systemic phenomena
beyond the intestinal environment, such as obesity (Turnbaugh
et al., 2006) and lifespan (Matsumoto et al., 2011), have been
reported. The bidirectional signaling between the gastrointesti-
nal tract and the brain, the gut-brain axis, is vital for main-
taining homeostasis and is regulated at the neural, hormonal,
and immunological levels. The importance of the gut-brain axis
is further emphasized by the high incidence of co-morbidities
between stress-related psychiatric disorders such as anxiety, and
gastrointestinal disorders (Camara et al., 2009). Recent studies
have investigated the effect of gut microbiota on brain and behav-
ior. The results of these studies suggest that intestinal microbiota
have a great impact on gut-brain communication, which led
to the coining of the term “microbiota-gut-brain axis” (MGB
axis) (Rhee et al., 2009; Cryan and Dinan, 2012). For example,
intestinal microbiota modulates brain development and subse-
quent adult behavior, such as motor activity and anxiety (Hei-
jtz et al., 2011; Neufeld et al., 2011). Studies on the MGB axis
have focused on the central nervous system (CNS), including the
Abbreviations: BBB, blood-brain barrier; CE-TOFMS, capillary electrophoresis
with time-of-flight mass spectrometry; CNS, central nervous system; DA, dopamine;
Ex-GF, ex-germ-free; GF, germ-free; MGB axis, microbiota-gut-brain axis; RSD,
relative standard deviations.
hypothalamic-pituitary-adrenal axis (Sudo et al., 2004; Rhee et al.,
2009), neurotransmitter, and synapse related factors (for exam-
ple, PSD-95, synaptophysin; Heijtz et al., 2011), and brain-derived
neurotrophic factor (Heijtz et al., 2011; Neufeld et al., 2011). How-
ever, to the best of our knowledge, other metabolites stimulated
by the MGB axis have not been investigated. Furthermore, some
metabolites may be synthesized independently in the brain and
may be influenced by MGB axis, while some metabolites produced
by intestinal bacteria may be transported from the colonic lumen
to the brain in the bloodstream without filtration by blood-brain
barrier (BBB).
Capillary electrophoresis with time-of-flight mass spectrome-
try (CE-TOFMS) is a novel strategy for analyzing and differentially
displaying metabolic profiles (Monton and Soga, 2007). Here,
using CE-TOFMS, we analyzed the cerebral metabolome obtained
from germ-free (GF) mice and Ex-GF mice, harboring intesti-
nal microbiota from specific pathogen-free mice and demon-




Germ-free BALB/c mice were purchased originally from Japan
Clea Inc. (Tokyo, Japan), and were bred in the Department of
Infectious Diseases, Tokai University School of Medicine, Kana-
gawa, Japan. We divided six male mice bred from mating into two
groups, GF mice (GF 1–3) and Ex-GF mice (Ex-GF 1–3). Mice
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were housed in Trexler-Type flexible film plastic isolators with
sterilized clean tip (CLEA Japan, Inc., Tokyo) as bedding. They
were given sterilized water and sterilized commercial CL-2 pellets,
which consisted of moisture (8.5%), crude protein (24.5%), crude
fat (8.0%), crude fiber (4.4%), crude ash (8.5%), and nitrogen free
extracts (48.2%), corresponding to 344.7 kcal/100 g (CLEA Japan,
Inc.), ad libitum. The diet was sterilized with an autoclave (121˚C,
30 min). Surveillance for bacterial contamination was performed
by periodic bacteriological examination of feces throughout the
experiments. Ex-GF mice were inoculated at 4 weeks of age into
the stomach by a metal catheter with 0.5 mL of a 10−1 suspension
of feces obtained from SPF BALB/c mice. The protocols approved
by the Kyodo Milk Animal Use Committee (Permit Number:
2009-02) and all experimental procedures were performed accord-
ing to the guidelines of the Animal Care Committee of Tokai
University.
SPECIMEN PREPARATION AND CE-TOFMS
Mice (7-week-old mice) were sacrificed by cervical dislocation.
The brain was resected on ice, and prefrontal cortex was sliced
between 2.5 and 3.5 mm anterior to bregma within 5 min of sac-
rifice. Immediately after the sacrifaction, cardiac blood (approxi-
mately approximately 100µl) was collected, and sodium ethylene-
diamine tetraacetate plasma (final concentration was 0.13%) was
prepared by centrifugation for 20 min at 2,300× g and 4˚C. The
samples were stored at−80˚C until use.
Cardiac plasma (50µl) and methanol (450µl) with 50µM
intestinal standard were vortexed. The plasma homogenate served
as crude metabolome and was added to chloroform (500µl) and
Milli-Q (200µl), mixed, and centrifuged (2,300× g, for 5 min at
4˚C). The aqueous layer was centrifugally filtered through a 5-
kDa cutoff filter Ultrafree-MC (Millipore). The filtrated solution
was dried up and suspended in 25µL Milli-Q water just before
the measurement. The cerebrums were suspended in methanol
(500µl) with 50µM intestinal standard and vortexed vigorously
five times for 60 s with a MicroSmash MS-100R (Tomy Digi-
tal Biology Co., Ltd., Tokyo, Japan) at 4,000 rpm. The result-
ing cerebrum sample served as crude metabolome that sub-
sequently underwent the same treatment as the plasma crude
metabolome.
Metabolomics measurement and data processing were per-
formed as described previously with an Agilent Capillary Elec-
trophoresis System (Ooga et al., 2011). The CE-MS system is the
Agilent G1600A Capillary Electrophoresis System connected with
the Agilent G1969A LC/MSD TOF (Agilent Technologies, Palo
Alto, CA, USA).
RNA PREPARATION AND QUANTITATIVE REAL-TIME PCR OF THE
CEREBRUMS
Frozen prefrontal cerebrums were processed for total RNA
preparation with TaKaRa FastPure RNA Kits (Takara Bio
Inc., Otsu, Japan). The quantity, purity, and integrity were
confirmed initially by electrophoresis. cDNA for each sam-
ple was synthesized using 200 ng total RNA and PrimeScript
RT reagent Kits (Takara Bio Inc.). Real-time PCR was per-
formed with a StepOne Real-Time PCR System (Applied
Biosystems) with TaqMan Fast Universal PCR Master Mix
(Applied Biosystems) using TaqMan probes (hexokinase 1:
Mm00439344_m1, phosphofructokinase: Mm00445461_m1, and
β-actin: Mm02619580_g1). The comparative delta C t method was
used for normalizations to the housekeeping gene β-actin.
INTESTINAL BACTERIAL COMPOSITIONS
Bacterial compositions were determined using pyrosequencing
system. Bacterial DNA was isolated from colonic content sam-
ples of mice. The 16S rRNA was targeted to identify intestinal
bacteria and a pair of universal primers; 27f (5 –AGA GTT TGA
TCC TGG CTC AG–3) and 350r (5 –CTG CTG CCT CCC GTA
G–3) were used for PCR. Amplicons were applied to GS titanium
sequencing Kit (Roche Diagnostics) include emulsion PCR and
analyzed by Genome sequencer FLX system (Roche Diagnostics).
About 18,000–20,500 sequences in each sample were identified.
Sequences data were compared with DDBJ database (Blast) and
classified by taxonomic categories.
DATA ANALYSIS AND STATISTICS
Clustering analysis in metabolome was processed by MATLAB
2008a (MathWorks, MA, USA). Differences in relative quantity
between GF mice and Ex-GF mice were evaluated for individual
metabolites by Welch’s t -test.
RESULTS
THE DIFFERENCE IN CEREBRAL METABOLOME BETWEEN GF AND
EX-GF MICE
When the mice were sacrificed, the body weights of GF mice were
between 22 and 24 g and those of Ex-GF mice were between 22
and 25 g. CE-TOFMS identified 196 (120 cations and 76 anions)
metabolites from the cerebral metabolome in both of GF and Ex-
GF mice. Hierarchical clustering of metabolite patterns is shown
in Figure 1A. A remarkable difference was observed in the cerebral
metabolome between GF and Ex-GF mice. Of the 196 metabolites
in the cerebral metabolome, the concentrations of 23 metabolites
were at least 1.6-fold, and/or significantly (p< 0.05) higher, in GF
mice than Ex-GF mice (group GF> Ex-GF). A further 15 metabo-
lites were at least 1.6-fold, and significantly (p< 0.05) higher,
in Ex-GF mice than GF mice (group GF< Ex-GF), and/or 158
metabolites showed no difference in concentration or incidence
between GF and Ex-GF mice (Figure 1B).
Identified metabolites were classified into eight categories and
are listed in Table A1 in Appendix (anion) and Table A2 (cation)
in Appendix. Metabolites, in which there are significant differences
between GF and Ex-GF mice, are shown in Tables 1 and 2.
INFLUENCE OF INTESTINAL MICROBIOTA ON CEREBRAL GLYCOLYTIC
METABOLISM
The relative quantities of the annotated metabolites in the
principal metabolic pathways are represented as bar graphs
(Figure 2). The concentrations of metabolites involved in gly-
colysis/gluconeogenesis pathways are characteristically higher in
GF mice than in Ex-GF mice. Therefore, we focused our work on
cerebral glycolytic metabolism (Figure 3A). The concentration of
ADP and NADH were significantly (p< 0.05) higher, while there
was a tendency for concentrations of ATP, AMP, and NAD+ to
be higher in GF mice than Ex-GF mice. The NADH/NAD+ ratio
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FIGURE 1 | Difference in the cerebral metabolome between GF mice and Ex-GF mice. (A) Hierarchical clustering showing patterns of metabolites. Red and
green indicate high and low concentrations of metabolites, respectively. (B)The number of cerebral metabolites in the group. GF>Ex-GF; GF≈Ex-GF; and
GF<Ex-GF.
Table 1 | Metabolites whose concentrations were higher in the cerebral metabolome of Ex-GF mice than in that of GF mice.
Compound name Category Mean SD Ratio
GF Ex-GF GF Ex-GF Ex-GF/GF
Trimethylamine N -oxide Alkylamino acid 1.87E-05 8.20E-05 3.37E-06 1.53E-05 4.39 *
N5-Ethylglutamine Alkylamino acid 6.06E-05 1.43E-04 6.62E-06 2.43E-05 2.36 *
Cysteine glutathione disulfide Peptide 3.12E-04 6.78E-04 2.78E-04 4.36E-04 2.17
2,3-Diphosphoglyceric acid 8.67E-05 1.61E-04 2.73E-05 3.98E-05 1.85 p<0.1
Cys Amino acid 8.61E-04 1.54E-03 7.09E-04 9.51E-04 1.79
2-Methylserine 4.90E-05 8.70E-05 4.25E-06 1.25E-05 1.78 *
3-Methylhistidine Alkylamino acid 6.14E-04 1.03E-03 6.71E-05 1.34E-04 1.68 *
Cystine Peptide 1.96E-05 3.28E-05 NA 5.53E-06 1.67
Trp Amino acid 9.74E-04 1.44E-03 2.74E-05 1.13E-04 1.48 *
Pipecolic acid 1.61E-04 2.33E-04 7.37E-07 1.28E-05 1.44 *
Tyr Amino acid 3.47E-03 4.75E-03 3.16E-04 3.81E-04 1.37 *
Phe Amino acid 3.74E-03 4.97E-03 1.44E-04 1.38E-04 1.33 ***
Asp Amino acid 2.72E-03 3.43E-03 2.78E-05 1.20E-04 1.26 **
Ribose 5-phosphate Energy 1.11E-04 1.32E-04 3.22E-06 9.09E-06 1.19 *
Gln Amino acid 7.12E-03 8.46E-03 1.74E-04 4.57E-04 1.19 *
*p< 0.05, **p<0.01, ***p<0.001 (GF vs. Ex-GF).
These metabolites have significant or more than 1.6-fold difference between GF mice and Ex-GF.
tended to be lower in GF mice than in Ex-GF mice (Figure 3B).
There was no difference in the expression of the hexokinase and
phosphofructokinase genes, between GF mice and Ex-GF mice
(Figure 3C).
COMPARISON OF INDIVIDUAL DIFFERENCES IN METABOLOME
BETWEEN COLONIC LUMINAL CONTENT, CARDIAC PLASMA, AND THE
CEREBRUM
Relative standard deviations (RSD%= value of standard devia-
tion/value of mean× 100) of metabolites in the colonic luminal
content, cardiac plasma, and the cerebrum of GF and Ex-GF mice
are shown in Figure 4. The RSD value of metabolites in the cere-
brum was similar between GF and Ex-GF mice. However, in Ex-GF
mice, the RSD values in cardiac plasma (p= 0.10) and colonic
luminal content (p< 0.001) were larger than in GF mice. In addi-
tion, in Ex-GF mice, the RSD values were the highest for colonic
content (vs. cardiac plasma, p< 0.01), followed by cardiac plasma
(vs. the cerebrum, p< 0.05) and the cerebrum. In contrast, in GF
mice, the RSD value did not differ between colonic content and
cardiac plasma, although that of cardiac plasma was greater than
that of the cerebrum (p< 0.05).
COMPARISONS OF METABOLITES BETWEEN COLONIC LUMINAL
CONTENT, CARDIAC PLASMA, AND THE CEREBRUM
We compared the 38 metabolites, which were significantly altered
between the cerebrum of GF and Ex-GF mice. The relative quanti-
tative ratio (Ex-GF/GF value) for the expression of each metabolite
in colonic luminal content, cardiac plasma, and the cerebrum are
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Table 2 | Metabolites whose concentrations were lower in the cerebral metabolome of Ex-GF mice than in that of GF mice.
Compound name Category Mean SD Ratio
GF Ex-GF GF Ex-GF Ex-GF/GF
N -Acetylneuraminic acid Alkylamino acid 1.03E-03 8.75E-04 4.35E-05 5.59E-05 0.85 *
N -Acetylaspartic acid Neuron transmitter 2.06E-01 1.72E-01 1.04E-02 8.54E-03 0.84 *
Pantothenic acid Co-enzyme 4.37E-04 3.58E-04 2.08E-05 3.18E-05 0.82 *
Biotin Co-enzyme 2.22E-04 1.79E-04 1.66E-05 1.83E-05 0.80 *
Ser Amino acid 1.05E-03 7.95E-04 6.49E-05 5.53E-05 0.76 **
ADP Nucleic acid 5.09E-03 3.85E-03 5.37E-04 1.32E-04 0.76 *
1-Methylnicotinamide Alkylamino acid 5.04E-05 3.71E-05 5.17E-06 5.00E-06 0.74 *
Ser-Glu Peptide 4.69E-05 3.42E-05 5.47E-06 4.85E-06 0.73 *
Succinic acid Energy 2.01E-02 1.45E-02 1.25E-03 1.68E-03 0.72 *
3-Phenylpropionic acid 1.23E-04 8.80E-05 1.30E-05 9.03E-06 0.71 *
Dihydroxyacetone phosphate Energy 2.02E-04 1.40E-04 1.23E-05 2.27E-05 0.69 *
IMP Nucleic acid 2.67E-03 1.84E-03 1.70E-04 2.63E-04 0.69 *
2-Hydroxybutyric acid 8.39E-05 5.77E-05 8.91E-06 8.28E-06 0.69 *
NADP+ Co-enzyme 8.69E-05 5.68E-05 3.79E-06 1.27E-05 0.65 *
Hydroxyproline Amino acid 1.64E-03 1.07E-03 3.18E-05 1.14E-04 0.65 **
NADH Co-enzyme 2.09E-04 1.35E-04 2.26E-05 2.52E-05 0.65 *
3-Phosphoglyceric acid 5.54E-04 3.44E-04 9.54E-05 2.31E-05 0.62 p<0.1
Glycerol 3-phosphate 3.77E-03 2.31E-03 2.93E-04 1.27E-03 0.61
Glucose 6-phosphate Energy 1.01E-04 6.03E-05 2.05E-05 2.93E-06 0.60 p<0.1
Fructose 6-phosphate Energy 2.68E-05 1.54E-05 7.92E-06 2.03E-06 0.57
Dopamine Neuron transmitter 5.26E-04 2.85E-04 2.16E-04 5.60E-05 0.54
Fructose 1,6-diphosphate Energy 5.43E-04 2.67E-04 1.52E-04 4.13E-05 0.49 p<0.1
Taurocholic acid Bile acid 1.51E-04 2.26E-05 3.08E-05 1.17E-05 0.15 **
*p<0.05, **p<0.01, ***p<0.001 (GF vs. Ex-GF).
These metabolites have significant or more than 1.6-fold difference between GF mice and Ex-GF.
shown in Figure 5. Six metabolites, which are shown in red, had
similar Ex-GF/GF ratios in all three sites. Although detected in the
cerebrum, 12 metabolites, which are shown in blue, were below
the detection limit in cardiac plasma. A total of 16 metabolites,
which are marked by the “#” symbol, had different Ex-GF/GF
ratios between the cerebrum and cardiac plasma. The Ex-GF/GF
ratios of all other metabolites did not differ between the three
specimens.
INTESTINAL BACTERIAL COMPOSITIONS
Bacterial compositions were analyzed using FLX systems and the
results are shown in Figure 6. Phylum Firmicutes (80%) and
phylum Bacteroidetes (about 6%) have been identified as dom-
inant populations in all samples. Following detailed classification
on the family level, the families Lactobacillaceae, Lachnospiraceae,
Clostridiaceae, and Bacteroidaceae were commonly detected and
constituted higher proportions in the population, i.e., 50–70, 3–
10, 2–5, and 2–4% respectively, than other families. However,
there were only small individual differences among the samples.
These families accounted for up to 60–70% of the total bacterial
population.
DISCUSSION
To the best of our knowledge, in a prior study by Fu et al. (2011),
the highest numbers of metabolites from brain tissue to date were
detected using GC-MS. In total, 118 metabolites were routinely
detected in more than 80% of samples in one or more of three
species (human, chimpanzee, or rhesus macaques), in at least one
brain region (prefrontal or cerebellar cortex). However, only 61
metabolites were annotated. CE-TOFMS identified 196 metabo-
lites from the cerebral metabolome, indicating that CE-TOFMS
is more sensitive than GC-MS for comprehensive and large-scale
metabolomic analysis in the brain.
NEUROTRANSMITTERS AND SEVERAL METABOLITES WHICH ARE
INVOLVED IN BRAIN FUNCTION
Concentration of dopamine (DA), a target for amphetamine stim-
ulation of locomotor activity and stereotyped behaviors, was
approximately twofold higher (p= 0.188) in GF mice than in
Ex-GF mice. This is consistent with the findings that GF mice
display increased motor activity and reduced anxiety compared
with their Ex-CF counterparts (Heijtz et al., 2011; Neufeld et al.,
2011). It is confusing that the concentration of Tyr in the cere-
brum of Ex-GF mice was higher than that of GF mice, since
Tyr is a precursor of DA. Tyr hydroxylase hydroxylates Tyr to l-
DOPA, which was below the detection limit in this study. DOPA
is further converted to DA by aromatic amino acid decarboxylase
(Daubner et al., 2011). Therefore, this indicates that cerebral DA
synthesis is induced by DA-producing enzymes, which are inhib-
ited by stimulation of intestinal microbiota through the MGB axis
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FIGURE 2 | Differences of cerebral metabolites between GF mice and
Ex-GF mice on the principal metabolic pathways. The relative quantities
of the annotated metabolites are represented as bar graphs (blue, GF: red,
Ex-GF). Metabolites surrounded by blue and red circles are of higher and
lower concentrations, respectively, in GF mice than Ex-GF mice. ND, not
detected.
(Figure 7A). Parkinson disease is characterized by a progressive
loss of dopaminergic neurons in the substantia nigra. Since the
activity level of Tyr hydroxylase is associated with Parkinson dis-
ease (Haavik and Toska, 1998), it is possible that the intestinal
microbiota is involved in the development of Parkinson disease.
We were also surprised to find that the concentrations of
Trp, precursors of serotonin (5-HT), in the cerebrum of Ex-GF
mice were higher than that of GF mice. This was despite the
fact that cerebral 5-HT concentration did not differ between
GF mice and Ex-GF mice (Figure 7B). It is believed that brain
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FIGURE 3 | Comparison of glycolytic metabolic activity between GF mice and Ex-GF mice. (A)The relative quantities of the annotated metabolites are
represented as bar graphs (blue, GF: red, Ex-GF). (B) Relative quantities of ATP, ADP, AMP, and nicotinamides (*p<0.05). (C) Cerebral gene expression of
hexokinase and phosphofructokinase. Data are represented as mean±SD (A,B) and mean±SEM (C).
5-HT concentration is dependent on the brain Trp level (Fern-
strom, 2005). Plasma Trp are transported into the brain by a
transporter, located at BBB on CNS capillary endothelial cells
(Pardridge, 1998), and converted to 5-HT in neurons contain-
ing Trp hydroxylase, the rate-limiting enzyme in 5-HT synthesis
(Jequier et al., 1967). Therefore, we suppose that cerebral 5-HT
synthesis is regulated by Trp hydroxylase in neurons without the
influence of the cerebral Trp pool and/or intestinal microbiota
under the non-stressed condition and in non-neonates, as in our
present study.
Several metabolites, which are known to be involved in brain
function, are also influenced by normal intestinal microbiota. N -
acetylaspartic acid (NAA), which is in group GF> Ex-GF, is an
amino acid present in the vertebrate brain that is synthesized
and stored primarily in neurons and considered a marker for
neuronal health and attenuation (Simmons et al., 1991; Jenkins
et al., 2000). Pipecolic acid, which is in the GF< Ex-GF group,
is known as a neuromodulator or neurotransmitter with the
gamma-aminobutyric acid (GABA)ergic transmission. Pipecolic
acid was shown to be region- and site-specific in the CNS (Kase
et al., 1980), which causes hepatic encephalopathy by induc-
ing neuronal cell death, or apoptosis, rather than by depressing
neurotransmissions (Matsumoto et al., 2003). Ser was in the
GF> Ex-GF group; d-Ser is synthesized from l-Ser by serine
racemase (CE-TOFMS could not separate d-Ser and l-Ser) in
the human brain. It functions as an obligatory co-agonist at
the glycine modulatory site of N -methyl-d-aspartate (NMDA)-
selective glutamate receptors. Thus, depletion of d-Ser levels
has been implicated in NMDA receptor hypofunction, which
is thought to occur in schizophrenia (Yang et al., 2010). N -
acetylneuraminic acid (NANA), which was in group GF> Ex-
GF, increased learning and memory performance (Wang et al.,
2007). These findings indicate that intestinal microbiota are closely
related to brain health, disease development, attenuation, learning,
and memory.
CEREBRAL ENERGY METABOLISM
The concentration of several cerebral glycolysis intermediates was
higher in GF mice than in Ex-GF mice (Figure 3A). This raises the
following two possibilities: first, the cerebral energy consumption
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FIGURE 4 |The boxplot of RSD% of all metabolites detected from colonic luminal content, cardiac plasma, and the cerebrum. Blue cross bars represent
the comparison of means between Ex-GF mice and GF mice. *p<0.05, **p<0.01, ***p<0.001 (GF vs. Ex-GF).
of Ex-GF mice is higher than that of GF mice, and second, that
cerebral energy production by glycolysis in Ex-GF mice is lower
than in GF mice. However, these phenomena presumably indicate
an accelerated molecular flux of the glycolysis pathway to compen-
sate for ATP and NADH depletion in the cerebrum of Ex-GF mice.
This assumption is based on our finding that the cerebral ATP (Ex-
GF/GF ratio= 0.91) and NADH (Ex-GF/GF ratio= 0.65) levels
were lower in Ex-GF mice than GF mice (Figure 3B) and there
was no difference in cerebral hexokinase and phosphofructoki-
nase gene expression between mice (Figure 3C). In fact, levels of
acetyl CoA, which is produced by oxidation from pyruvic acid,
was similar in the cerebrum of GF and Ex-GF mice. Furthermore,
a significant difference in lactic acid was not observed, suggesting
that the normal intestinal microbiota do not influence anaerobic
respiration and the compensated molecular components (ATP or
NADH) of the glycolysis pathway in Ex-GF mice was then trans-
ferred into the TCA cycle for further aerobic respiration via acetyl
CoA in the cerebral mitochondria. To support the presence of an
active TCA cycle, we also report changes in NADH and NAD+.
The ratio between NADH and NAD+ affects mitochondrial TCA
cycle activity (LaNoue et al., 1972). NADH and NADH/NAD+
ratio in Ex-GF mice were reduced to 65 and 92% of those in GF
mice, respectively. Since both values are known to increase when
the TCA cycle is blocked (Sugiura et al., 2011), the observed reduc-
tions in NADH and NADH/NAD+ ratio suggest normal intestinal
microbiota induces active oxidative phosphorylation via the TCA
cycle. From these findings, we suggest that, in the cerebrum, Ex-GF
mice consume energy and accelerate energy production through
glycolysis and TCA cycle more highly than GF mice. In other
word, the cerebrum of Ex-GF mice is more active than that of
GF mice.
BACTERIAL POTENTIAL INFLUENCE ON CEREBRUMMETABOLIC
CHANGES
Of 38 metabolites influenced by intestinal microbiota, 12 metabo-
lites detected from the cerebrum but not cardiac plasma, are
synthesized independently in the cerebrum and are influenced by
MGB axis (Figure 5, metabolites shown in blue). Sixteen metabo-
lites whose Ex-GF/GF ratio differed between the cerebrum and
cardiac plasma are influenced by MGB axis and/or BBB (Figure 5,
metabolites marked by #). The fact that NANA is in this group is
in conflict existing literature. In animal infant models, exogenous
administration of NANA increased learning and memory perfor-
mance as well as the concentration of NANA in the frontal cortex
(Carlson and House, 1986; Wang et al., 2007). However, in the
present study, NANA produced by intestinal microbiota was not
transported to the blood. Therefore, it is doubtful whether dietary
NANA influences the brain and behavior directly. We suppose
that improvement of learning and memory performance by oral
administration of NANA depends on the stimulation of intestinal
microbiota, which is altered by supplements containing NANA
through the MBG axis. Cerebral GABA concentration did not
differ between GF mice and Ex-GF mice, although remarkable
differences were observed in GABA cardiac plasma concentrations
between GF mice and Ex-GF mice (Figure 8). This indicates that
GABA is controlled by BBB and tightly regulated in the cerebrum.
This questions the suitability of oral GABA supplementation
studies to provide GABA to the brain.
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FIGURE 5 | Relative quantitative ratio (Ex-GF/GF value) comparisons of
38 metabolites between GF mice and Ex-GF mice, colonic luminal
content, cardiac plasma, and the cerebrum. Metabolites shown in red have
similar Ex-GF/GF ratios between the colonic lumen, cardiac plasma, and the
cerebrum. Metabolites shown in blue are below the detection limit in cardiac
plasma, but were detected in the cerebrum. #These metabolites differed in
Ex-GF/GF ratios between the cerebrum and cardiac plasma. *p<0.05,
**p<0.01, ***p<0.001 (GF vs. Ex-GF). ND, not detected.
Differences in RSD values between GF mice and Ex-GF mice
(Figure 4) implies that individual differences in the metabo-
lites found in the colonic content and cardiac plasma of Ex-
GF mice is influenced by the diversity of intestinal microbiota
(Matsumoto et al., 2012). Furthermore, these findings indi-
cate that many metabolites produced by intestinal bacteria are
filtrated and transported to brain via the blood through the
BBB. However, six cerebral metabolites (Figure 5, metabolites
shown in red) had similar Ex-GF/GF ratios between colonic
luminal content, cardiac plasma, and the cerebrum. This may
suggest that these metabolites may be transported from the
colonic lumen to the cerebrum in the bloodstream without fil-
tration by BBB. Further studies are required to fully under-
stand how these metabolites are transported from the gut lumen
to blood and from blood to the brain. Furthermore, the rela-
tionship between intestinal bacterial composition and brain
metabolome is an area that clearly merits further study in the
future.
These discussions center on a comparison between general
knowledge and the data obtained in the present study. However,
the neuronal effects of almost detected metabolites in the cere-
brum are unclear. In future studies, researchers in various fields
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FIGURE 6 | Aggregate microbiota composition at the phylum and family levels in the colonic content of Ex-GF mice.
FIGURE 7 | Relative quantitative comparisons of metabolites in the
biosynthetic pathway for dopamine (A) and serotonin (B), in the
cerebrum of GF mice and Ex-GF mice. Data are represented as
mean±SD. *p<0.05, ***p<0.001 (GF vs. Ex-GF).
may find evidence that some of the newly identified metabolites
are important for neuronal activities and diseases. Indeed, there is
a possibility of detecting site-specific metabolome profiles when
FIGURE 8 | Relative quantitative comparisons of GABA in colonic
lumen content, cardiac plasma, and the cerebrum. Data are represented
as mean±SD. **p<0.01.
using CE-TOFMS. Further studies are required to analyze other
parts of the brain.
In this study, many metabolites including neurotransmitters
showed differences in the concentrations between GF mice and
Ex-GF mice, indicating that normal intestinal microbiota closely
connected with brain health and disease, development, attenua-
tion, learning, memory, and behavior. We propose that through
proper control of intestinal microbiota, cerebral nerve disorders
may be prevented or alleviated in the future.
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